Barinthus Biotherapeutics

Developer of T-cell immunotherapeutics to treat multiple diseases

placeGermantown, Maryland, United States calendar_todayFounded 2016 language barinthusbio.com

Registered entities

Innovation

11 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 278 times.

YearFilings
20131
20191
20213
20233
20245
20256
20261

Social engagement

Social engagement: 10.5K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Sequoia Capital, Google Ventures, Oxford Science Enterprises, M&G; 1 has since exited.

Investor typeCountShare
Venture capital750%
Private equity214%
Accelerator & incubator17%
Other / undisclosed429%

Recent activity

13 Mar 2026
Milestone
regulatory
7 Jan 2026
Partnership
Clywedog Therapeutics Inc
7 Nov 2025
Milestone
regulatory
Coming soon